Literature DB >> 15636015

Cellular neuroplasticity mechanisms mediating pain persistence.

Michael W Salter1.   

Abstract

Transmission of noxious-stimulus-evoked inputs in the spinal and trigeminal systems is mediated primarily through excitatory glutamatergic synapses using alpha amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) subtypes of glutamate receptors. Glutamatergic synapses exhibit multiple forms of short-lasting and long-lasting synaptic plasticity. Persistent enhancement of nociceptive transmission, known as "central sensitization," is a form of lasting plasticity that is similar mechanistically to long-term potentiation of glutamatergic transmission in other regions of the central nervous system. This potentiation of AMPA/kainate transmission is dependent upon the activity of NMDA receptors, which become enhanced following noxious peripheral stimulation as a result of several convergent mechanisms. Central sensitization is thus an expression of increased synaptic gain at glutamatergic synapses in central nociceptive-transmission neurons and thereby contributes importantly to pain hypersensitivity. In addition, recent evidence has revealed a new player in the mechanisms underlying pain hypersensitivity following nerve injury--microglia. Understanding of the roles of microglia may lead to new strategies for the diagnosis and management of neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15636015

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  22 in total

Review 1.  Endometriosis and abdominal myofascial pain in adults and adolescents.

Authors:  John Jarrell
Journal:  Curr Pain Headache Rep       Date:  2011-10

2.  Lasting changes in a network of interneurons after synapse regeneration and delayed recovery of sensitization.

Authors:  A K Urazaev; S Arganda; K J Muller; C L Sahley
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

3.  Decreased pain response in mice following cortex-specific knockout of the N-methyl-D-aspartate NR1 subunit.

Authors:  Gabriel C Quintero; Reha S Erzurumlu; Anthony L Vaccarino
Journal:  Neurosci Lett       Date:  2007-08-19       Impact factor: 3.046

Review 4.  Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit.

Authors:  Adeleke D Adewumi; Christine E Staatz; Samantha A Hollingworth; Jason P Connor; Rosa Alati
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

5.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

6.  Interleukin-1 beta enhances endocytosis of glial glutamate transporters in the spinal dorsal horn through activating protein kinase C.

Authors:  Xisheng Yan; Ruchi Yadav; Mei Gao; Han-Rong Weng
Journal:  Glia       Date:  2014-03-26       Impact factor: 7.452

7.  Central sensitization in medullary dorsal horn involves gap junctions and hemichannels.

Authors:  Chen Yu Chiang; Zhaohui Li; Jonathan O Dostrovsky; Barry J Sessle
Journal:  Neuroreport       Date:  2010-02-17       Impact factor: 1.837

8.  Activation of peripheral P2X receptors is sufficient to induce central sensitization in rat medullary dorsal horn nociceptive neurons.

Authors:  Pavel S Cherkas; Jonathan O Dostrovsky; Barry J Sessle
Journal:  Neurosci Lett       Date:  2012-08-14       Impact factor: 3.046

9.  Glutamine uptake contributes to central sensitization in the medullary dorsal horn.

Authors:  Chen Yu Chiang; Zhaohui Li; Jonathan O Dostrovsky; James W Hu; Barry J Sessle
Journal:  Neuroreport       Date:  2008-07-16       Impact factor: 1.837

10.  Movement restriction does not modulate sensory and perceptual effects of exercise-induced arm pain.

Authors:  Markus Hübscher; Simon Tu; Tasha Stanton; G Lorimer Moseley; Benedict M Wand; John Booth; James H McAuley
Journal:  Eur J Appl Physiol       Date:  2014-12-24       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.